Cargando…

Differences in bioavailability and cognitive-enhancing activity exerted by different crystal polymorphs of latrepirdine (Dimebon(®))

Introduction: Pharmacokinetic characteristics as well as cognitive-enhancing nootropic activity of latrepirdine (Dimebon(®)) in relationship with its polymorphic forms have been studied in SD and Wistar rats. Methods: The pharmacokinetics of six polymorphs (A, B, C, D, E, F) of latrepirdine were stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gorin, Boris I., Tukhovskaya, Elena A., Ismailova, Alina M., Slashcheva, Gulsara A., Lenina, Oksana A., Petrov, Konstantin A., Kazeev, Ilya V., Murashev, Arkady N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992171/ https://www.ncbi.nlm.nih.gov/pubmed/36909182 http://dx.doi.org/10.3389/fphar.2023.1091858

Ejemplares similares

Delta Sleep-Inducing Peptide Recovers Motor Function in SD Rats after Focal Stroke
por: Tukhovskaya, Elena A., et al.
Publicado: (2021)

DSIP-Like KND Peptide Reduces Brain Infarction in C57Bl/6 and Reduces Myocardial Infarction in SD Rats When Administered during Reperfusion
por: Tukhovskaya, Elena A., et al.
Publicado: (2021)

A bioisostere of Dimebon/Latrepirdine delays the onset and slows the progression of pathology in FUS transgenic mice
por: Chaprov, Kirill, et al.
Publicado: (2021)

Acute dosing of latrepirdine (Dimebon™), a possible Alzheimer therapeutic, elevates extracellular amyloid-β levels in vitro and in vivo
por: Steele, John W, et al.
Publicado: (2009)

Mitochondrial Pharmacology of Dimebon (Latrepirdine) Calls for a New Look at its Possible Therapeutic Potential in Alzheimer’s Disease
por: Eckert, Schamim H, et al.
Publicado: (2018)

Design, Synthesis, Molecular Docking Study and Biological Evaluation of Novel γ-Carboline Derivatives of Latrepirdine (Dimebon) as Potent Anticancer Agents
por: Voggu, Ramakrishna, et al.
Publicado: (2023)

Dimebon disappointment
por: Jones, Roy W
Publicado: (2010)

Evaluation of Dimebon in cellular model of Huntington's disease
por: Wu, Jun, et al.
Publicado: (2008)

AICAR Improves Outcomes of Metabolic Syndrome and Type 2 Diabetes Induced by High-Fat Diet in C57Bl/6 Male Mice
por: Tukhovskaya, Elena A., et al.
Publicado: (2022)

C-Terminal Region of Caveolin-3 Contains a Stretch of Amino Acid Residues Capable of Diminishing Symptoms of Experimental Autoimmune Encephalomyelitis but Not Rheumatoid Arthritis Modeled in Rats
por: Danilkovich, Alexey V., et al.
Publicado: (2023)

Derinat(®) has an immunomodulatory and anti-inflammatory effect on the model of acute lung injury in male SD rats
por: Palikova, Yulia A., et al.
Publicado: (2022)

Screening of the Promising Direct Thrombin Inhibitors from Haematophagous Organisms. Part I: Recombinant Analogues and Their Antithrombotic Activity In Vitro
por: Kostromina, Maria A., et al.
Publicado: (2021)

The Effects of Latrepirdine on Amyloid-β Aggregation and Toxicity
por: Porter, Tenielle, et al.
Publicado: (2016)

Balanced modulation of neuromuscular synaptic transmission via M1 and M2 muscarinic receptors during inhibition of cholinesterases
por: Lenina, Oksana A., et al.
Publicado: (2022)

Dimebon Slows Progression of Proteinopathy in γ-Synuclein Transgenic Mice
por: Bachurin, Sergey O., et al.
Publicado: (2011)

Efficacy of Ficus tikoua Bur. extract in ethylene glycol-induced urolithiasis model in SD rats
por: Bervinova, Arina V., et al.
Publicado: (2022)

Latrepirdine stimulates autophagy and reduces accumulation of α-synuclein in cells and in mouse brain
por: Steele, John W., et al.
Publicado: (2012)

Preclinical study of dimebon on β-amyloid-mediated neuropathology in Alzheimer's disease
por: Wang, Jun, et al.
Publicado: (2011)

Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases
por: Bharadwaj, P R, et al.
Publicado: (2013)

Latrepirdine is a potent activator of AMP-activated protein kinase and reduces neuronal excitability
por: Weisová, P, et al.
Publicado: (2013)

Slow-binding reversible inhibitor of acetylcholinesterase with long-lasting action for prophylaxis of organophosphate poisoning
por: Lenina, Oksana A., et al.
Publicado: (2020)

Dimebon Does Not Ameliorate Pathological Changes Caused by Expression of Truncated (1–120) Human Alpha-Synuclein in Dopaminergic Neurons of Transgenic Mice
por: Shelkovnikova, Tatyana A., et al.
Publicado: (2011)

Azemiopsin, a Selective Peptide Antagonist of Muscle Nicotinic Acetylcholine Receptor: Preclinical Evaluation as a Local Muscle Relaxant
por: Shelukhina, Irina V., et al.
Publicado: (2018)

First-In-Human Trials of GamTBvac, a Recombinant Subunit Tuberculosis Vaccine Candidate: Safety and Immunogenicity Assessment
por: Vasina, Daria V., et al.
Publicado: (2019)

Selective targeting of α7 nicotinic acetylcholine receptor by synthetic peptide mimicking loop I of human SLURP-1 provides efficient and prolonged therapy of epidermoid carcinoma in vivo
por: Shlepova, O. V., et al.
Publicado: (2023)

The Endocannabinoid Reuptake Inhibitor WOBE437 Is Orally Bioavailable and Exerts Indirect Polypharmacological Effects via Different Endocannabinoid Receptors
por: Reynoso-Moreno, Inés, et al.
Publicado: (2018)

Interfacial Bond-Breaking Electron Transfer in Mixed Water–Ethylene Glycol Solutions: Reorganization Energy and Interplay between Different Solvent Modes
por: Ismailova, Oksana, et al.
Publicado: (2013)

Enhancement of the Transdermal Delivery of Nonsteroidal Anti-inflammatory Drugs Using Liposomes Containing Cationic Surfactants
por: Kuznetsova, Darya A., et al.
Publicado: (2022)

Specific inhibition of acetylcholinesterase as an approach to decrease muscarinic side effects during myasthenia gravis treatment
por: Petrov, Konstantin A., et al.
Publicado: (2018)

Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer’s Disease
por: Semenov, Vyacheslav E., et al.
Publicado: (2022)

Accounting for differences in the bioactivity and bioavailability of vitamers
por: Gregory, Jesse F.
Publicado: (2012)

Supramolecular Tools to Improve Wound Healing and Antioxidant Properties of Abietic Acid: Biocompatible Microemulsions and Emulgels
por: Mirgorodskaya, Alla, et al.
Publicado: (2022)

Novel Acetylcholinesterase Inhibitors Based on Uracil Moiety for Possible Treatment of Alzheimer Disease
por: Semenov, Vyacheslav E., et al.
Publicado: (2020)

Autonomic Dysfunction Determines Stress-Induced Cardiovascular and Immune Complications in Mice
por: Batchu, Sri N, et al.
Publicado: (2015)

Phenotypic differences in nebivolol metabolism and bioavailability in healthy volunteers
por: BRICIU, CORINA, et al.
Publicado: (2015)

Characterization and Bioavailability of Wogonin by Different Administration Routes in Beagles
por: Zhu, Na, et al.
Publicado: (2016)

Pharmacokinetics and bioavailability of doxycycline in ostriches (Struthio camelus) at two different dose rates
por: Abu-Basha, Ehab A., et al.
Publicado: (2006)

Bone Marrow-Derived Multipotent Stromal Cells Promote Myocardial Fibrosis and Reverse Remodeling of the Left Ventricle
por: Fatkhudinov, Timur, et al.
Publicado: (2015)

Vitamins and Microelement Bioavailability in Different Stages of Chronic Kidney Disease
por: Jankowska, Magdalena, et al.
Publicado: (2017)

Dissolution and bioavailability improvement of bioactive apigenin using solid dispersions prepared by different techniques
por: Alshehri, Sultan M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ot9bg6kd7m9pdtjid07nqm86d0